BioCentury | Jun 27, 2016
Financial News

Response Biomedical completes private placement

...Raised: $500,000 Shares: 892,858 Price: $0.56 Shares after offering: 10.8 million Investor: OrbiMed Advisors Note: Response Biomedical...
BioCentury | Jun 20, 2016
Financial News

Response Biomedical proposes private placement

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 2016-06-16 Type: Private placement To be raised: $1 million Shares: 1.8 million Price: $0.56 Shares outstanding prior: 9.9 million Investors: OrbiMed Advisors; Shanghai Runda...
BioCentury | Sep 22, 2014
Company News

Response Biomedical management update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Promoted: Barbara Kinnaird to COO from VP Resigned: Jeffrey Purvin as president, CEO and a director; Anthony Holler, a director, becomes interim CEO WIR Staff Diagnostic...
BioCentury | Sep 8, 2014
Company News

Response Biomedical board of directors update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Appointed: Lewis Shuster, a director, as chairman; he succeeds Peter Thompson, who remains a director WIR Staff Diagnostic...
BioCentury | Apr 15, 2013
Company News

Response Biomedical board of directors update

Response Biomedical Corp. (VSE:RBM), Vancouver, B.C. Business: Diagnostics/Imaging Appointed: Harvey Hoyt, M.D., consultant for ExSource Associates Inc. WIR Staff Diagnostic...
BioCentury | Nov 12, 2012
Clinical News

RAMP D-dimer assay regulatory update

...is used as an aid in ruling out whether a patient has venous thromboemoblism (VTE). Response Biomedical Corp....
BioCentury | Aug 6, 2012
Company News

Response Biomedical management update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Hired: Tim Shannon as SVP of worldwide sales and marketing, a newly created position, formerly VP of vascular at Teleflex Inc. WIR Staff Diagnostic...
BioCentury | Jan 16, 2012
Financial News

Response Biomedical completes rights offering of units

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date completed: 12/30/11 Type: Rights offering of units Raised: C$6.7 million ($6.5 million) Shares: 90.1 million Price: C$0.07 (unit) Shares after offering: 129.1 million Investors: Existing...
BioCentury | Dec 5, 2011
Financial News

Response Biomedical amends rights offering of units

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 11/28/11 Type: Rights offering of units To be raised: Up to C$8 million ($7.9 million) Shares: 107.2 million Price: C$0.07 (unit) Shares outstanding prior:...
BioCentury | Nov 21, 2011
Financial News

Response Biomedical proposes rights offering of units

Response Biomedical Corp. (TSX: RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 11/14/11 Type: Rights offering of units To be raised: Up to C$8 million ($7.9 million) Shares: TBD Price prior: C$0.16 Shares outstanding prior:...
Items per page:
1 - 10 of 102
BioCentury | Jun 27, 2016
Financial News

Response Biomedical completes private placement

...Raised: $500,000 Shares: 892,858 Price: $0.56 Shares after offering: 10.8 million Investor: OrbiMed Advisors Note: Response Biomedical...
BioCentury | Jun 20, 2016
Financial News

Response Biomedical proposes private placement

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 2016-06-16 Type: Private placement To be raised: $1 million Shares: 1.8 million Price: $0.56 Shares outstanding prior: 9.9 million Investors: OrbiMed Advisors; Shanghai Runda...
BioCentury | Sep 22, 2014
Company News

Response Biomedical management update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Promoted: Barbara Kinnaird to COO from VP Resigned: Jeffrey Purvin as president, CEO and a director; Anthony Holler, a director, becomes interim CEO WIR Staff Diagnostic...
BioCentury | Sep 8, 2014
Company News

Response Biomedical board of directors update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Appointed: Lewis Shuster, a director, as chairman; he succeeds Peter Thompson, who remains a director WIR Staff Diagnostic...
BioCentury | Apr 15, 2013
Company News

Response Biomedical board of directors update

Response Biomedical Corp. (VSE:RBM), Vancouver, B.C. Business: Diagnostics/Imaging Appointed: Harvey Hoyt, M.D., consultant for ExSource Associates Inc. WIR Staff Diagnostic...
BioCentury | Nov 12, 2012
Clinical News

RAMP D-dimer assay regulatory update

...is used as an aid in ruling out whether a patient has venous thromboemoblism (VTE). Response Biomedical Corp....
BioCentury | Aug 6, 2012
Company News

Response Biomedical management update

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Hired: Tim Shannon as SVP of worldwide sales and marketing, a newly created position, formerly VP of vascular at Teleflex Inc. WIR Staff Diagnostic...
BioCentury | Jan 16, 2012
Financial News

Response Biomedical completes rights offering of units

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date completed: 12/30/11 Type: Rights offering of units Raised: C$6.7 million ($6.5 million) Shares: 90.1 million Price: C$0.07 (unit) Shares after offering: 129.1 million Investors: Existing...
BioCentury | Dec 5, 2011
Financial News

Response Biomedical amends rights offering of units

Response Biomedical Corp. (TSX:RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 11/28/11 Type: Rights offering of units To be raised: Up to C$8 million ($7.9 million) Shares: 107.2 million Price: C$0.07 (unit) Shares outstanding prior:...
BioCentury | Nov 21, 2011
Financial News

Response Biomedical proposes rights offering of units

Response Biomedical Corp. (TSX: RBM; OTCBB:RPBIF), Vancouver, B.C. Business: Diagnostic Date announced: 11/14/11 Type: Rights offering of units To be raised: Up to C$8 million ($7.9 million) Shares: TBD Price prior: C$0.16 Shares outstanding prior:...
Items per page:
1 - 10 of 102